|
1
|
Roach HI: The complex pathology of
osteoarthritis: even mitochondria are involved. Arthritis Rheum.
58:2217–2218. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Berenbaum F: New horizons and perspectives
in the treatment of osteoarthritis. Arthritis Res Ther. 10(Suppl
2): S12008. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Dieppe P: Osteoarthritis of the knee in
primary care. BMJ. 336:105–106. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Gay S, Gay RE and Koopman WJ: Molecular
and cellular mechanisms of joint destruction in rheumatoid
arthritis: two cellular mechanisms explain joint destruction? Ann
Rheum Dis. 52(Suppl 1): S39–S47. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kvien TK: Epidemiology and burden of
illness of rheumatoid arthritis. Pharmacoeconomics. 22:1–12. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Beasley J: Osteoarthritis and rheumatoid
arthritis: conservative therapeutic management. J Hand Ther.
25:163–171. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Scott DL and Symmons DP: The role of
specialists in managing established rheumatoid arthritis.
Rheumatology (Oxford). 47:237–238. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Biswas S, Manikandan J and Pushparaj PN:
Decoding the differential biomarkers of Rheumatoid arthritis and
Osteoarthritis: A functional genomics paradigm to design disease
specific therapeutics. Bioinformation. 6:153–157. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ungethuem U, Haeupl T, Witt H, et al:
Molecular signatures and new candidates to target the pathogenesis
of rheumatoid arthritis. Physiol Genomics. 42A:267–282. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Irizarry RA, Hobbs B, Collin F, et al:
Exploration, normalization and summaries of high density
oligonucleotide array probe level data. Biostatistics. 4:249–264.
2003. View Article : Google Scholar
|
|
11
|
Smyth GK: Linear models and empirical
bayes methods for assessing differential expression in microarray
experiments. Stat Appl Genet Mol Biol. 3:32004.PubMed/NCBI
|
|
12
|
Benjamini Y and Hochberg Y: Controlling
the false discovery rate: a practical and powerful approach to
multiple testing. J R Stat Soc Series B Stat Methodol. 57:289–300.
1995.
|
|
13
|
Huang DW, Sherman BT and Lempicki RA:
Systematic and integrative analysis of large gene lists using DAVID
bioinformatics resources. Nat Protoc. 4:44–57. 2009.PubMed/NCBI
|
|
14
|
Huang da W, Sherman BT and Lempicki RA:
Bioinformatics enrichment tools: paths toward the comprehensive
functional analysis of large gene lists. Nucleic Acids Res.
37:1–13. 2009.PubMed/NCBI
|
|
15
|
Lamb J, Crawford ED, Peck D, et al: The
connectivity map: using gene-expression signatures to connect small
molecules, genes and disease. Science. 313:1929–1935. 2006.
View Article : Google Scholar
|
|
16
|
Sondergaard BC, Schultz N, Madsen SH,
Bay-Jensen AC, Kassem M and Karsdal MA: MAPKs are essential
upstream signaling pathways in proteolytic cartilage
degradation-divergence in pathways leading to aggrecanase and
MMP-mediated articular cartilage degradation. Osteoarthritis
Cartilage. 18:279–288. 2010. View Article : Google Scholar
|
|
17
|
Lawrence MC, Jivan A, Shao C, et al: The
roles of MAPKs in disease. Cell Res. 18:436–442. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kotovuori A, Pessa-Morikawa T, Kotovuori
P, Nortamo P and Gahmberg CG: ICAM-2 and a peptide from its binding
domain are efficient activators of leukocyte adhesion and integrin
affinity. J Immunol. 162:6613–6620. 1999.PubMed/NCBI
|
|
19
|
Kaplan R, Morse B, Huebner K, et al:
Cloning of three human tyrosine phosphatases reveals a multigene
family of receptor-linked protein-tyrosine-phosphatases expressed
in brain. Proc Natl Acad Sci U S A. 87:7000–7004. 1990. View Article : Google Scholar
|
|
20
|
Wang A and Dennis EA: Mammalian
lysophospholipases. Biochim Biophys Acta. 1439:1–16. 1999.
View Article : Google Scholar
|
|
21
|
Peyrard M, Fransson I, Xie YG, et al:
Characterization of a new member of the human beta-adaptin gene
family from chromosome 22q12, a candidate meningioma gene. Hum Mol
Genet. 3:1393–1399. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ferrara JL, Levine JE, Reddy P and Holler
E: Graft-versus-host disease. Lancet. 373:1550–1561. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Weetman AP and McGregor AM: Autoimmune
thyroid disease: further developments in our understanding. Endocr
Rev. 15:788–830. 1994.PubMed/NCBI
|
|
24
|
López-Franco O, Hernández-Vargas P,
Ortiz-Muñoz G, et al: Parthenolide modulates the NF-kappaB-mediated
inflammatory responses in experimental atherosclerosis.
Arterioscler Thromb Vasc Biol. 26:1864–1870. 2006.PubMed/NCBI
|
|
25
|
Yip KH, Zheng MH, Feng HT, Steer JH, Joyce
DA and Xu J: Sesquiterpene lactone parthenolide blocks
lipopolysaccharide-induced osteolysis through the suppression of
NF-kappaB activity. J Bone Miner Res. 19:1905–1916. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Guzman ML, Rossi RM, Karnischky L, et al:
The sesquiterpene lactone parthenolide induces apoptosis of human
acute myelogenous leukemia stem and progenitor cells. Blood.
105:4163–4169. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Miglietta A, Bozzo F, Gabriel L and Bocca
C: Microtubule-interfering activity of parthenolide. Chem Biol
Interact. 149:165–173. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Feltenstein MW, Schuhly W, Warnick JE,
Fischer NH and Sufka KJ: Anti-inflammatory and anti-hyperalgesic
effects of sesquiterpene lactones from Magnolia and Bear’s foot.
Pharmacol Biochem Behav. 79:299–302. 2004.PubMed/NCBI
|
|
29
|
Tiuman TS, Ueda-Nakamura T, Garcia Cortez
DA, et al: Antileishmanial activity of parthenolide, a
sesquiterpene lactone isolated from Tanacetum parthenium.
Antimicrob Agents Chemother. 49:176–182. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Leost M, Schultz C, Link A, et al:
Paullones are potent inhibitors of glycogen synthase kinase-3beta
and cyclin-dependent kinase 5/p25. Eur J Biochem. 267:5983–5994.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lahusen T, De Siervi A, Kunick C and
Senderowicz AM: Alsterpaullone, a novel cyclin-dependent kinase
inhibitor, induces apoptosis by activation of caspase-9 due to
perturbation in mitochondrial membrane potential. Mol Carcinog.
36:183–194. 2003. View
Article : Google Scholar
|
|
32
|
Hoppener JW, de Pagter-Holthuizen P,
Geurts van Kessel AH, et al: The human gene encoding insulin-like
growth factor I is located on chromosome 12. Hum Genet. 69:157–160.
1985. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Jansen M, van Schaik FM, Ricker AT, et al:
Sequence of cDNA encoding human insulin-like growth factor I
precursor. Nature. 306:609–611. 1983. View
Article : Google Scholar : PubMed/NCBI
|
|
34
|
Studer RK: Nitric oxide decreases IGF-1
receptor function in vitro; glutathione depletion enhances this
effect in vivo. Osteoarthritis Cartilage. 12:863–869. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Retief E, Parker MI and Retief AE:
Regional chromosome mapping of human collagen genes alpha 2(I) and
alpha 1(I) (COLIA2 and COLIA1). Hum Genet. 69:304–308. 1985.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Wenstrup RJ, Cohn DH, Cohen T and Byers
PH: Arginine for glycine substitution in the triple-helical domain
of the products of one alpha 2(I) collagen allele (COL1A2) produces
the osteogenesis imperfecta type IV phenotype. J Biol Chem.
263:7734–7740. 1988.
|
|
37
|
Kikuno R, Nagase T, Ishikawa K, et al:
Prediction of the coding sequences of unidentified human genes. XIV
The complete sequences of 100 new cDNA clones from brain which code
for large proteins in vitro. DNA Res. 6:197–205. 1999. View Article : Google Scholar
|
|
38
|
FitzPatrick DR, Carr IM, McLaren L, et al:
Identification of SATB2 as the cleft palate gene on 2q32-q33. Hum
Mol Genet. 12:2491–2501. 2003. View Article : Google Scholar : PubMed/NCBI
|
